Company overview — key questions
Answers are generated from SEC filings and StockHuntr's analysis. Not investment advice.
What is Organon & Co. (OGN)?
Organon & Co. is a publicly traded company in the Healthcare space tracked on StockHuntr, which analyzes its SEC filings (10-K, 10-Q, 8-K) and generates 30-day stock predictions.
What are OGN's most recent SEC filings?
Recent filings: 10-Q (July 31, 2026), 8-K (July 31, 2026), 8-K (July 23, 2026), 8-K (July 17, 2026), 8-K (June 11, 2026).
What does OGN's latest filing analysis show?
OGN's most recent 10-Q (July 31, 2026) is rated CAUTIOUS, concern level HIGH.
What is the 30-day outlook for OGN?
Based on OGN's latest filing, the model predicts it will underperform the S&P 500 by about 0.0% over 30 days. This is model analysis for research, not investment advice.
Loading OGN snapshot...
Fetching live market data